Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Français (Suisse)
Italiano
Nederlands (Nederland)
Nederlands (België)
Markets
Equities
North America
Europe
Asia
Oceania
Middle East
»
More Equities
Indexes
S&P 500
DOW JONES
NASDAQ 100
EURO STOXX 50
NIKKEI 225
»
More Indexes
Currency / Forex
USD / EUR
USD / CAD
USD / MXN
USD / BRL
USD / INR
»
More Currencies
Commodities
GOLD
Crude Oil (WTI)
Crude Oil (BRENT)
SILVER
PLATINUM
»
More Commodities
Trackers & ETF
Rankings and News
Advanced Search
Cryptocurrencies
BITCOIN
ETHEREUM
News
Latest News
Companies
Markets
Economy
Currency / Forex
Commodities
Interest Rates
Business Leaders
Cryptocurrencies
Cybersecurity
Economic Calendar
Listed companies
Analyst Reco.
Rumors
IPOs
Capital Markets Transactions
New Contracts
Profit Warnings
Appointments
Press Releases
Events
Security Transactions
Financial Calendar
Sector News
Energy
Basic Materials
Industrials
Consumer Cyclical
Consumer Non-Cyclical
Financials
Healthcare
Technology
Telecommunications Services
Utilities
Analysis
All Analysis
Must Read
Daily Briefing
Weekly market update
Stock Trading Strategies
Stock Picks
All Stock Picks
Subscribe
Portfolios
My Portfolio
Virtual Portfolios
MarketScreener Portfolios
USA Portfolio
European Portfolio
Asian Portfolio
Watchlists
My Watchlists
Watchlists
My previous session
My most visited
Most popular
Investment Style
Quality stocks
Momentum stocks
ESG stocks
Growth stocks
Multibaggers
Undervalued stocks
Investment Themes
E-Commerce & Logistics
The genomic revolution
Smart City
Powerful brands
Israeli innovation
Ageing Population
Rankings
Top News
Most Read News
Hot News
Top Fundamentals
Top Capitalization
Top Yield
Top PER
Top Consensus
Top Fundamentals
Top ranking ESG
Top Technicals
Top RSI
Unusual volumes
Top Gaps
Top STIM
Breakouts
Trends
Top Movers
Top USA
Top Canada
Top U.K.
Top Germany
Top Europe
Top Asia
Screeners
Investment Themes
E-Commerce & Logistics
The genomic revolution
Smart City
Powerful brands
Israeli innovation
Ageing Population
Technical Rankings
Oversold stocks
Overbought stocks
Close to resistance
Close to support
Accumulation Phases
Most volatile stocks
Fundamental Rankings
Top Investor Rating
Top Trading Rating
Top Consensus
Growth stocks
Yield stocks
Low valuations
Stock Screener Home
My Screeners
All my stocks
Watchlists
Virtual Portfolios
Tools
MarketScreener tools
Stock Screener
iPhone App
Expert tools
Stock Screener PRO
Portfolio Creator
Event Screener
Dynamic Chart
Financial Calendar
Economic Calendar
Apprendre la bourse
ProRealTime Trading
Our Services
MarketScreener Portfolios
European Portfolio
USA Portfolio
Asian Portfolio
Our Stock Picks
Thematic Investment Lists
Stock Screener
Homepage
Equities
France
Euronext Paris
Nicox SA.
News
Official Publications
COX
FR0013018124
NICOX SA.
(COX)
Add to my list
Report
Real-time Euronext Paris -
05/18 08:34:27 am EDT
1.800
EUR
+1.12%
05/16
Ophthalmology Group Nicox Appoints New CEO, Chairman
MT
05/16
Nicox Announces a New Governance Structure
GL
05/16
Nicox Announces a New Governance Structure
AQ
Summary
Quotes
Charts
News
Ratings
Calendar
Company
Financials
Consensus
Revisions
Summary
Most relevant
All News
Other languages
Press Releases
Official Publications
Sector news
Official Publications
05/04/22
Mixed general Shareholders meeting
04/29/22
Report
02/28/22
Monthly statement on outstanding equity shares and voting rights
02/28/22
Monthly statement on outstanding equity shares and voting rights
01/31/22
Monthly statement on outstanding equity shares and voting rights
01/31/22
Monthly statement on outstanding equity shares and voting rights
01/27/22
Crossing thresholds
01/21/22
4th quarter earnings
12/31/21
Monthly statement on outstanding equity shares and voting rights
12/31/21
Monthly statement on outstanding equity shares and voting rights
12/13/21
Nomination
12/09/21
Public takeover bid
12/09/21
Report
11/30/21
Monthly statement on outstanding equity shares and voting rights
11/30/21
Monthly statement on outstanding equity shares and voting rights
10/31/21
Monthly statement on outstanding equity shares and voting rights
10/31/21
Monthly statement on outstanding equity shares and voting rights
10/19/21
3rd quarter earnings
10/19/21
3rd quarter earnings
09/30/21
Monthly statement on outstanding equity shares and voting rights
09/30/21
Monthly statement on outstanding equity shares and voting rights
09/27/21
Half-year results
09/27/21
Half-year results
08/31/21
Monthly statement on outstanding equity shares and voting rights
08/31/21
Monthly statement on outstanding equity shares and voting rights
07/31/21
Monthly statement on outstanding equity shares and voting rights
07/31/21
Monthly statement on outstanding equity shares and voting rights
07/16/21
2nd quarter earnings
07/16/21
2nd quarter earnings
06/30/21
Monthly statement on outstanding equity shares and voting rights
06/30/21
Monthly statement on outstanding equity shares and voting rights
06/30/21
Half-year report
06/30/21
Half-year report
05/31/21
Monthly statement on outstanding equity shares and voting rights
05/31/21
Monthly statement on outstanding equity shares and voting rights
05/03/21
Periodical releases - commercial and industrial companies - annual accounts
04/30/21
Monthly statement on outstanding equity shares and voting rights
04/30/21
Monthly statement on outstanding equity shares and voting rights
04/28/21
Press Release
04/28/21
Proxy Statments
04/28/21
Proxy Statments
04/19/21
1st quarter earnings
04/16/21
Mixed general Shareholders meeting notice
03/31/21
Monthly statement on outstanding equity shares and voting rights
03/31/21
Monthly statement on outstanding equity shares and voting rights
03/26/21
Ordinary general Shareholders meeting notice
03/05/21
Mixed general Shareholders meeting notice
03/01/21
Report
03/01/21
Press Release
03/01/21
Annual results
03/01/21
Annual results
02/28/21
Monthly statement on outstanding equity shares and voting rights
02/28/21
Monthly statement on outstanding equity shares and voting rights
02/15/21
Corporate Officers and Executives' transactions in the company's securities - Purchase
01/31/21
Monthly statement on outstanding equity shares and voting rights
01/31/21
Monthly statement on outstanding equity shares and voting rights
01/20/21
4th quarter earnings
01/20/21
4th quarter earnings
12/31/20
Report
12/31/20
Monthly statement on outstanding equity shares and voting rights
12/31/20
Monthly statement on outstanding equity shares and voting rights
12/03/20
Crossing thresholds
11/30/20
Monthly statement on outstanding equity shares and voting rights
10/31/20
Monthly statement on outstanding equity shares and voting rights
10/31/20
Monthly statement on outstanding equity shares and voting rights
10/20/20
3rd quarter earnings
10/20/20
3rd quarter earnings
09/30/20
Monthly statement on outstanding equity shares and voting rights
09/30/20
Monthly statement on outstanding equity shares and voting rights
09/10/20
Half-year results
08/31/20
Monthly statement on outstanding equity shares and voting rights
08/31/20
Monthly statement on outstanding equity shares and voting rights
08/14/20
2nd quarter earnings
08/14/20
2nd quarter earnings
08/14/20
Monthly statement on outstanding equity shares and voting rights
1
2
Next
Official Publications
05/04
Mixed general Shareholders meeting
04/29
Report
02/28
Monthly statement on outstanding equity sh..
02/28
Monthly statement on outstanding equity sh..
01/31
Monthly statement on outstanding equity sh..
01/31
Monthly statement on outstanding equity sh..
More Official Publications
Upcoming event on NICOX SA.
06/04/22
European Glaucoma Society Congress
Company calendar
Upcoming sector events
05/31/22
DOTTIKON ES HOLDING AG
: FY 2022 Earnings Release (Projected)
07/29/22
YUHAN CORPORATION
: Interim 2022 Earnings Release (Projected)
08/04/22
KYOWA KIRIN CO., LTD.
: Interim 2022 Earnings Release
08/04/22
MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN
: Interim 2022 Earnings Release
More events
Sector
Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Specialty & Advanced Pharmaceuticals
Slave